JEDI is a Research to Business project funded by Business Finland to commercialize the research innovation from the Biomedical Spectroscopy Lab, University of Eastern Finland, Kuopio, Finland. The project’s mission will be to develop solutions that will revolutionize orthopaedic surgery through evidence-based diagnostics by enabling rapid and non-destructive diagnosis of tissue pathology without compromising workflows.

The ultimate goal is to develop novel technologies to support clinicians in delivering optimal to enable better patient outcomes. Upon completion of the project, the optimal commercialisation pathway for JEDI to support objective assessment of tissue integrity during joint surgery will be determined and implemented.